Identification of a Signature for Predicting Prognosis and Immunotherapy Response in Patients with Glioma

Figure 5

The expression of RAB3A, TYROBP, SYP, CAMK2A, VSIG4, and GABRA1 (a–f) in GSE2223 microarray data. The expression of RAB3A, SYP, CAMK2A, and GABRA1 were decreased, and expression of TYROBP and VSIG4 were increased in glioma samples. ROC curves of RAB3A, TYROBP, SYP, CAMK2A, VSIG4, and GABRA1 (g–l) in GSE2223 microarray data. ROC: receiver operating characteristic.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)